Secondary hypertension

Reading File

Finding Sources

Searching PubMed

"secondary hypertension" AND diagnosis

Searching the Web

secondary hypertension causes diagnosis management 2025 guidelines

Reading File

Finding Sources

Reading File

Loading Image

Reading File

I now have rich, comprehensive material from multiple authoritative textbooks plus current guidelines. Let me compose the full answer.

Secondary Hypertension

Secondary hypertension refers to elevated blood pressure with an identifiable, potentially reversible underlying cause. It accounts for approximately 5-10% of all hypertension cases in adults, though this figure is likely an underestimate given historical underdiagnosis of primary aldosteronism and sleep apnea. In children, secondary causes are the rule rather than the exception - up to 90% of hypertensive young children have an identifiable cause. - National Kidney Foundation Primer on Kidney Diseases, 8e

When to Suspect It

According to Harrison's (22nd ed, 2025), secondary hypertension should be considered in all patients with new-onset hypertension and specifically in established hypertensives who show:

Treatment-resistant hypertension (BP uncontrolled on ≥3 drugs)
Abrupt worsening of previously controlled hypertension
Disproportionate target organ damage relative to BP level
Suggestive lab findings - unprovoked hypokalemia, proteinuria, or unexplained LVH

Patients with resistant hypertension have particularly high rates: primary aldosteronism ~20%, renovascular disease ~25%, and OSA >50%. - NKF Primer

Classification of Causes

Secondary hypertension categories: Vascular, Endocrinologic, Toxic, and Other

1. Vascular Causes

Cause	Key Features	Diagnosis	Treatment
Renal artery stenosis	Abdominal bruit (esp. diastolic), acute renal function decline after ACEi/ARB	Doppler US (initial); conventional angiography (gold standard)	Revascularization (PTRA or stent); ACEi/ARB avoid bilaterally
Coarctation of the aorta	BP higher in arms than legs, rib notching on CXR, radio-femoral delay, S4 gallop	Echo, CT/MR angiography	Surgical or catheter-based repair
Vasculitis (e.g. PAN)	Multi-system involvement, hepatitis B association	Biopsy, angiography	Immunosuppression

Renal artery stenosis may account for up to 20% of resistant hypertension cases. Fibromuscular dysplasia (FMD) is the most common cause in children and young women, producing the classic "string of beads" appearance on angiography. Atherosclerosis predominates in older patients. - Frameworks for Internal Medicine

String-of-beads appearance of FMD on angiography

2. Endocrinologic Causes

Cause	Prevalence	Mechanism	Screening Test	Treatment
Primary aldosteronism (Conn's)	Up to 10% of all hypertensives	Autonomous aldosterone excess → Na retention, K wasting	Aldosterone:renin ratio >30	Adrenalectomy (adenoma); spironolactone (hyperplasia)
Obstructive sleep apnea (OSA)	Most common secondary cause overall	Intermittent hypoxia → sympathetic activation, RAAS dysregulation	Polysomnography	CPAP; weight loss
Pheochromocytoma	Rare (~0.2% of hypertensives)	Catecholamine excess → episodic or sustained HTN	24h urinary metanephrines/catecholamines; plasma metanephrines	Surgical resection (after alpha-blockade)
Cushing's syndrome	Varies	Glucocorticoid activity at mineralocorticoid receptor	24h urinary free cortisol (most reliable); dexamethasone suppression	Treat underlying cause (surgery, medication)
Hypothyroidism	~20% of hypothyroid patients have HTN	Increased SVR, reduced cardiac output	TSH + free T4	Thyroid hormone replacement (HTN usually resolves)
Hyperthyroidism	Isolated systolic HTN, wide pulse pressure	High cardiac output state	TSH + T4	Treat thyroid disorder; beta-blockers interim
Hyperparathyroidism/hypercalcemia	Less common	Direct Ca-mediated increase in SVR and renal vascular resistance	Serum Ca, PTH	Treat hypercalcemia; avoid thiazides
Acromegaly	~1/3 of acromegaly patients	GH/IGF-1 effects on vasculature and kidneys	Serum IGF-1	Surgery; somatostatin analogues

Key notes:

Primary aldosteronism is classically associated with mild hypernatremia, hypokalemia, and metabolic alkalosis - but this triad is not always present, so the aldosterone:renin ratio should be checked regardless of potassium level (a key update in the 2025 AHA/ACC guidelines).
OSA: more than half of US adults with OSA have hypertension; direct correlation between OSA severity and BP level/resistance.
Cushing's: hypertension present in ~20% with iatrogenic Cushing's, but up to 95% with ectopic ACTH secretion.

3. Renal Parenchymal Disease

The most prevalent overall cause when considering all age groups. Includes:

Chronic kidney disease (hypertension present in the majority)
Acute glomerulonephritis
Polycystic kidney disease
Scleroderma renal crisis

Mechanism: sodium and water retention, RAAS activation, impaired vasodilator production. - Frameworks for Internal Medicine

4. Toxic / Drug-Induced Causes

Agent	Mechanism / Notes
NSAIDs	Prostaglandin inhibition → Na/water retention; average +5 mmHg; more pronounced in treated hypertensives
Oral contraceptives	Estrogen-mediated RAAS activation; risk 2-3x higher; risk factors: gestational HTN hx, obesity, smoking
Glucocorticoids	Mineralocorticoid receptor activation → Na retention; respond to salt restriction + diuretics
Sympathomimetics (ephedrine, pseudoephedrine, methylphenidate, oxymetazoline)	Adrenergic stimulation; avoid beta-blockers (unopposed alpha-vasoconstriction risk)
Cocaine	Blocks norepinephrine reuptake → sympathetic surge; tachycardia + hypertension; can cause pulmonary hypertension with chronic use
Alcohol	Dose-dependent; HTN develops 2-3 days after withdrawal
Cyclosporine / tacrolimus	Vasoconstriction, renal effects
Erythropoietin	Increased blood viscosity and vasoconstriction

5. Other Causes

Cause	Details
Pregnancy	Gestational hypertension, preeclampsia, eclampsia; methyldopa is first-line agent
Neurologic	Increased ICP (Cushing's response), quadriplegia, dysautonomia, Guillain-Barre syndrome
White-coat hypertension	24h ambulatory BP monitoring helpful for diagnosis

Diagnostic Approach

Initial Evaluation (all hypertensive patients)

Full history: medications (OCP, NSAIDs, steroids, sympathomimetics), snoring/witnessed apneas, headaches/palpitations/sweating (pheochromocytoma), weight gain/striae (Cushing's)
Exam: BP in both arms, radial-femoral pulse delay, abdominal bruits, body habitus
Basic labs: serum electrolytes (hypokalemia → aldosteronism), renal function, urinalysis, TSH, fasting glucose, lipids

Targeted Testing by Suspected Cause

Suspected Cause	First-Line Test
Primary aldosteronism	Plasma aldosterone:renin ratio (>30 suggestive)
OSA	Polysomnography
Renal artery stenosis	Renal Doppler ultrasound
Pheochromocytoma	24h urinary metanephrines or plasma metanephrines
Cushing's syndrome	24h urinary free cortisol
Hypothyroidism/hyperthyroidism	TSH + free T4
Coarctation	Echo, BP in all 4 limbs, CXR (rib notching)
Acromegaly	Serum IGF-1

Management Principles

The key principle is treating the underlying cause. Many secondary causes are potentially curative:

Primary aldosteronism (adenoma): adrenalectomy normalizes BP in ~50%; spironolactone/eplerenone for bilateral hyperplasia
Renal artery stenosis (FMD): percutaneous transluminal renal angioplasty (PTRA) - excellent response
Coarctation: surgical or catheter repair
Pheochromocytoma: surgical resection after adequate alpha-blockade (phenoxybenzamine or selective alpha-1 blocker)
OSA: CPAP reduces BP (modest effect, more pronounced in resistant hypertension)
Hypothyroidism: thyroid hormone replacement
Drug-induced: discontinue offending agent where possible

Where cure is not possible, antihypertensive therapy should be tailored to the underlying mechanism (e.g., mineralocorticoid receptor antagonists for primary aldosteronism, ACEi/ARB for renovascular disease - with caution in bilateral stenosis).

2025 AHA/ACC Guideline Updates

The 2025 AHA/ACC Hypertension Guidelines introduced several key changes relevant to secondary hypertension:

Expanded primary aldosteronism screening regardless of potassium levels (addressing longstanding underdiagnosis)
Renal denervation introduced as a Class IIb adjunctive option for resistant hypertension
Greater emphasis on ABPM and home BP monitoring for diagnostic accuracy
Expanded guidance for special populations including CKD, diabetes, and pregnancy

Sources: - Harrison's Principles of Internal Medicine 22e (2025) | - Frameworks for Internal Medicine | - NKF Primer on Kidney Diseases, 8e | - Comprehensive Clinical Nephrology, 7e | 2024 ESC Hypertension Guidelines (PMID 39210715) | Endocrine Society Primary Aldosteronism Guideline 2025 (PMID 40658480)

CURB 65

Finding Sources

Searching PubMed

"CURB-65" AND "community-acquired pneumonia"

Searching the Web

CURB-65 score pneumonia 2025 guidelines validation

Finding Sources

Reading File

I now have comprehensive, authoritative content from multiple textbooks. Here is the full answer:

CURB-65

CURB-65 is a validated clinical scoring tool for assessing the severity of community-acquired pneumonia (CAP) and guiding site-of-care decisions. It was developed and validated by the British Thoracic Society (BTS) and assigns 1 point per criterion, for a maximum score of 5.

The 5 Criteria (1 point each)

Letter	Criterion	Threshold
C	Confusion	New-onset disorientation to person, place, or time
U	Urea (blood urea nitrogen)	BUN >7 mmol/L (>20 mg/dL in US units)
R	Respiratory rate	≥30 breaths/min
B	Blood pressure	Systolic ≤90 mmHg or diastolic ≤60 mmHg
65	Age	≥65 years

Note: In the US, BUN >20 mg/dL is the equivalent threshold; the original BTS study used urea >7 mmol/L.

Score Interpretation and Management

Score	30-day Mortality	Risk Class	Recommended Action
0	~1.5%	Low	Outpatient treatment
1	~2.7%	Low	Outpatient (consider inpatient if age ≥65 is the sole point)
2	~9.2%	Moderate	Short inpatient admission or supervised outpatient care
3	~17-22%	Severe	Inpatient admission; assess for ICU
4	~41.5%	Severe	Inpatient; strong consideration for ICU
5	~57%	Severe	ICU admission

Key thresholds from the validation data:

Score 0-1: Low risk; outpatient management is generally safe
Score 2: Moderate risk; brief hospitalization or close outpatient follow-up
Score ≥3: High risk; hospitalization required; ICU consideration for score 4-5
Harrison's Principles of Internal Medicine 22e (2025)

Important Caveats

1. Age as a Confounding Factor

If the entire or partial contribution to the score is age ≥65 alone, hospitalization may not be necessary. Age by itself does not always indicate clinical severity - clinical context matters. - Harrison's 22e

2. Does Not Determine ICU Need

Neither CURB-65 nor PSI is accurate for ICU admission decisions. Patients with the following warrant direct ICU admission regardless of score:

Septic shock requiring vasopressors
Acute respiratory failure requiring mechanical ventilation

For less obvious cases, the IDSA/ATS minor criteria framework is used: ICU admission is appropriate with ≥3 of:

RR ≥30/min
PaO₂/FiO₂ ≤250
Multilobar infiltrates
Confusion/disorientation
BUN ≥20 mg/dL
WBC <4,000 cells/μL
Platelets <100,000 cells/μL
Core temperature <36°C
Hypotension requiring aggressive IV fluids
Symptom to Diagnosis, 4e; Harrison's 22e

3. Clinical Judgment Must Supplement the Score

Among patients with the same CURB-65 score, mortality in those clinically deemed to need admission was 1.7-26x higher than those felt safe for discharge. The score supports, but does not replace, clinical judgment. Additional factors to consider:

Inability to maintain oral intake
Medication compliance concerns (cognitive impairment, homelessness)
SpO₂ <92% on room air (independently mandates admission)
Severity of comorbidities relative to the score
Social support and barriers to follow-up
Symptom to Diagnosis, 4e; Fishman's Pulmonary Diseases

CURB-65 vs. Pneumonia Severity Index (PSI)

Feature	CURB-65	PSI
Variables	5	20
Ease of use	Simple; bedside calculable	Complex; requires labs
Guideline preference	British Thoracic Society	IDSA-ATS (preferred)
Performance	Good	Slightly superior for 30-day mortality prediction; classifies more patients as low-risk
Electronic integration	Easier	More difficult
Limitations	Less sensitive to logistic/social factors; variable performance in low/middle-income countries	Age-weighted (less useful at age extremes); not validated in children

The PSI has more robust validation and is recommended by the IDSA-ATS guidelines, but CURB-65 is widely preferred clinically for its simplicity and ease of bedside use. - Fishman's Pulmonary Diseases and Disorders; Murray & Nadel's Textbook of Respiratory Medicine

CRB-65: The Simplified Variant

For settings where BUN measurement is not immediately available (e.g., primary care), CRB-65 omits the urea criterion. Scores of 0 carry very low mortality; scores ≥2 warrant hospital referral. It is less well-validated than CURB-65 but practically useful. - Tintinalli's Emergency Medicine

Context: Where Does CURB-65 Fit in CAP Management?

Once CURB-65 guides the site-of-care decision, management continues with:

Outpatient (score 0-1): Amoxicillin, doxycycline, or azithromycin for 5 days (healthy adults); add coverage for drug-resistant organisms in those with comorbidities (respiratory fluoroquinolone, or beta-lactam + macrolide/doxycycline)
Inpatient non-ICU (score 2-3): Beta-lactam + macrolide/doxycycline, or respiratory fluoroquinolone monotherapy
ICU (score ≥4 or meets major/minor criteria): Broad-spectrum coverage including atypical organism coverage; consider MRSA/Pseudomonas risk factors

Sources: - Harrison's Principles of Internal Medicine 22e (2025) | - Fishman's Pulmonary Diseases and Disorders | - Murray & Nadel's Textbook of Respiratory Medicine | - Goldman-Cecil Medicine | - Symptom to Diagnosis, 4e | - Tintinalli's Emergency Medicine

MELD score

Finding Sources

Searching PubMed

"MELD score" AND "liver transplantation"

Searching the Web

MELD score MELD-Na MELD 3.0 liver transplant 2024 2025

Reading File

Finding Sources

Reading File

I have all the data I need for a comprehensive answer - including the original MELD formula, MELD-Na, MELD 3.0, the mortality table, and comparison with Child-Pugh. Let me compile the full answer now.

MELD Score (Model for End-Stage Liver Disease)

Overview

The MELD score was originally developed to predict 90-day (3-month) mortality in patients undergoing TIPS (transjugular intrahepatic portosystemic shunt) placement for complications of portal hypertension. It was later shown to accurately predict survival across a broad range of advanced liver disease states - cirrhosis with infections, variceal bleeding, cholestatic diseases, acute liver failure, and alcoholic hepatitis - and was adopted by UNOS (United Network for Organ Sharing) in 2002 as the primary tool for liver transplant prioritization, replacing the Child-Turcotte-Pugh (CTP) score. - Current Surgical Therapy 14e; Sabiston Textbook of Surgery

Versions of MELD

1. Original MELD (Pre-2016)

Uses 3 objective laboratory variables:

$$\text{MELD} = [0.957 \times \ln(\text{Cr}) + 0.378 \times \ln(\text{Bili}) + 1.120 \times \ln(\text{INR}) + 0.643] \times 10$$

Variable	Notes
Serum creatinine (mg/dL)	Capped at 4.0 mg/dL; set to 4.0 if on hemodialysis (≥2 sessions or 24h CVVHD in prior week)
Serum bilirubin (mg/dL)	Total bilirubin
INR	Prothrombin time as INR
Constant	+0.643

Score range: 6-40 (UNOS caps at 40 for allocation purposes). Result is multiplied by 10 and rounded to the nearest integer. - Tietz Textbook of Laboratory Medicine, 7e

2. MELD-Na (UNOS Standard 2016-2021)

Adds serum sodium to address hyponatremia as an independent predictor of waitlist mortality. Multiple studies showed MELD-Na predicts waitlist mortality ~7% better than original MELD.

$$\text{MELD-Na} = \text{MELD} + 1.59 \times (135 - \text{Na})$$

Sodium capped between 125-137 mEq/L
Became the OPTN/UNOS standard in January 2016

3. MELD 3.0 (Current US Standard since 2022)

Developed to address sex-based disparities in organ allocation (women had historically lower waitlist-to-transplant rates). MELD 3.0 adds female sex and serum albumin as variables, plus interaction terms:

$$\text{MELD 3.0} = 1.33(\text{Female}) + 4.56\ln(\text{Bili}) + 0.82(137-\text{Na}) - 0.24(137-\text{Na})\ln(\text{Bili}) + 9.09\ln(\text{INR}) + 11.14\ln(\text{Cr}) + 1.85(3.5-\text{Alb}) - 1.83(3.5-\text{Alb})\ln(\text{Cr}) + 6$$

(Rounded to nearest integer)

New variables in MELD 3.0 vs. earlier versions:

Female sex: +1.33 points
Serum albumin (g/dL): incorporated with interaction term with creatinine
Creatinine capped at 3.0 mg/dL (lowered from 4.0 in prior versions)
Interaction terms between bilirubin-sodium and albumin-creatinine

MELD 3.0 is the current OPTN/UNOS standard in the United States. - Sabiston Textbook of Surgery; Kim WR et al., Gastroenterology 2021

3-Month Mortality by MELD Score

MELD Score	3-Month Mortality
7	~1%
20	~8%
24	~10%
26	~15%
29	~20%
31	~30%
33	~40%
35	~50%
≥40	>70%

Broad risk categories:

MELD <10: Low risk
MELD 10-20: Intermediate risk
MELD >20: High risk - candidates strongly benefit from transplantation
Tietz Textbook of Laboratory Medicine, 7e; Current Surgical Therapy 14e

Clinical Uses

1. Liver Transplant Prioritization

Higher MELD = higher waitlist priority. Key threshold:

MELD <15: Transplant may not be beneficial - post-transplant mortality can exceed waitlist mortality at this score. Transplantation generally deferred.
MELD 15-20: Benefit of transplant starts to favor proceeding
MELD ≥21: Clear benefit - transplantation strongly indicated

2. Perioperative Risk Stratification (Non-Transplant Surgery)

MELD <16: Lower postoperative mortality
MELD ≥16: Significantly higher postoperative mortality
MELD increase positively correlates with postoperative mortality for any major surgery
Studies show increased hospital cost and length of stay in cirrhotic patients even without portal hypertension - Sabiston Textbook of Surgery

3. TIPS Outcome Prediction

The original application. MELD <18 before TIPS associated with better outcomes.

4. Disease Monitoring

Serial MELD scores track disease progression. A rising MELD ("delta MELD") is associated with worsening prognosis.

MELD vs. Child-Turcotte-Pugh (CTP) Score

Feature	MELD	CTP
Variables	Bilirubin, INR, Creatinine, Na (±sex, albumin in 3.0)	Bilirubin, INR, Albumin, Ascites, Encephalopathy
Type	Continuous mathematical model	Categorical (A/B/C)
Objectivity	Fully objective (lab-based)	Semi-subjective (ascites, encephalopathy grading)
Mortality prediction	Superior for short-term (90-day)	Less accurate
Allocation use	Current UNOS standard	Replaced (used historically)
Renal function	Captured (creatinine)	Not captured
Ceiling effect	Capped at 40	Less precise at extremes

MELD is superior to CTP for predicting short-term survival in cirrhosis. - Tietz Laboratory Medicine 7e

Exception Points (MELD Upgrades)

Some conditions confer mortality risk not fully captured by MELD lab values. UNOS allows "exception points" (MELD upgrade) for: - Sabiston Textbook of Surgery

Hepatocellular carcinoma (HCC) - within Milan criteria
Hepatopulmonary syndrome
Portopulmonary hypertension (mean PAP <35 mmHg on treatment)
Familial amyloid polyneuropathy
Primary hyperoxaluria
Cystic fibrosis
Hilar cholangiocarcinoma (meeting specific criteria)
Hepatic artery thrombosis within 14 days of transplant

Conditions that may qualify for exception points include refractory ascites, refractory hepatic encephalopathy, refractory variceal hemorrhage, and portal hypertensive gastropathy with chronic blood loss.

Special Populations

Children <12 years: Use PELD (Pediatric End-Stage Liver Disease) score instead
Hemodialysis patients: Creatinine automatically set to 4.0 mg/dL (original MELD) or 3.0 mg/dL (MELD 3.0) if on RRT
HCC patients: MELD/PELD score is increased according to UNOS algorithm to account for cancer-related mortality risk not reflected in biochemical parameters

Regarding recent evidence: A 2024 review (PMID 37751367) confirms MELD 3.0 improves upon MELD-Na with better sex equity and predictive accuracy in advanced chronic liver disease. The 2025 Endocrine Society Primary Aldosteronism guideline and 2025 AHA/ACC hypertension guideline do not affect MELD interpretation. No evidence currently contradicts the MELD 3.0 framework.

Sources: - Sabiston Textbook of Surgery | - Current Surgical Therapy 14e | - Tietz Textbook of Laboratory Medicine 7e | - Harrison's Principles of Internal Medicine 22e (2025) | - Barash Clinical Anesthesia 9e | Kim WR et al., MELD 3.0 original derivation paper, Gastroenterology 2021

This is a shared conversation. Sign in to Orris to start your own chat.